Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus

American Journal of Cardiology

Volumn 102, Issue 10, 2008, Pages 1328-1334

  Patti, Giuseppe ^a   Nusca, Annunziata ^a   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PACLITAXEL; RAPAMYCIN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY STENT; DIABETIC PATIENT; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INSULIN TREATMENT; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; SYSTEMATIC REVIEW; THROMBOSIS;

CORONARY STENOSIS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 55249110044     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.012     Document Type: Article

References (27)

1. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
2. In: Higgins J.P.T., and Green S. (Eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. Updated May 2005. The Cochrane Library, Issue 3 (2005), John Wiley & Sons, Chichester, UK. http://www.cochrane.org/resources/handbook/hbook.htm Available at: http://www.cochrane.org/resources/handbook/hbook.htm. Accessed 2008.
3. Altman D.G., and Schulz K.F. Statistics notes: concealing treatment allocation in randomized trials. BMJ 323 (2001) 446-447
4. Juni P., Witschi A., Bloch R., and Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (1999) 1054-1060
5. Sabate M., Jimenez-Quevedo P., Angiolillo D.J., Gomez-Hospital J.A., Alfonso F., Hernandez-Antolin R., Goicolea J., Banuelos C., Escaned J., Moreno R., et al., DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation 112 (2005) 2175-2183
6. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
8. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
9. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
10. Schampaert E., Cohen E.A., Schluter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., Popma J.J., and C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
11. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
12. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., Repetto M., Merlini P.A., and SES-SMART Investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292 (2004) 2727-2734
13. Dawkins K.D., Grube E., Guagliumi G., Banning A.P., Zmudka K., Colombo A., Thuesen L., Hauptman K., Marco J., Wijns W., et al., TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
14. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
15. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabaté M., Suttorp M.J., Baumgart D., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
16. Patti G., Pasceri V., Melfi R., Goffredo C., Chello M., D'Ambrosio A., Montesanti R., and Di Sciascio G. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 111 (2005) 70-75
17. Aronson D., Bloomgarden Z., and Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 27 (1996) 528-535
18. Carrozza Jr. J.P., Kuntz R.E., Fishman R.F., and Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 118 (1993) 344-349
19. Di Sciascio G., Patti G., Nasso G., Manzoli A., D'Ambrosio A., and Abbate A. Early and long-term results of stenting of diffuse coronary artery disease. Am J Cardiol 86 (2000) 1166-1170
20. Boyden T.F., Nallamothu B.K., Moscucci M., Chan P.S., Grossman P.M., Tsai T.T., Chetcuti S.J., Bates E.R., and Gurm H.S. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Am J Cardiol 99 (2007) 1399-1402
21. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.J., and Schomig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32 (1998) 1866-1873
22. Moreno R., Fernandez C., Calvo L., Sanchez-Recalde A., Galeote G., Sanchez-Aquino R., Alfonso F., Macaya C., and Lopez-Sendon J.L. Meta-analysis comparing the effect of drug-eluting versus bare metal stents on risk of acute myocardial infarction during follow-up. Am J Cardiol 99 (2007) 621-625
23. Daemen J., Garcia-Garcia H.M., Kukreja N., Imani F., de Jaegere P.P., Sianos G., van Domburg R.T., and Serruys P.W. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 28 (2007) 26-32
24. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
25. Jimenez-Quevedo P., Sabatè M., Angiolillo D.J., Alfonso F., Hernandez-Antolin R., SanMartin M., Gomez-Hospital J.A., Banuelos C., Escaned J., Moreno R., et al. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial. Eur Heart J 28 (2007) 1946-1952
26. Kirtane A.J., Ellis S.G., Dawkins K.D., Colombo A., Grube E., Popma J.J., Fahy M., Leon M.B., Moses J.W., Mehran R., and Stone G.W. Paclitaxel-eluting coronary stents in patients with diabetes mellitus. J Am Coll Cardiol 51 (2008) 708-715
27. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591